Literature DB >> 11062601

Hypertension in patients presenting with stroke.

B J Pearson1, P M Bath, J D Spence.   

Abstract

Hypertension is a major risk factor for stroke disease. There is now some international agreement on what constitutes hypertension, and at what level of blood pressure treatment is required. Large randomised controlled trials demonstrate the benefit of reducing blood pressure for the primary and secondary prevention of stroke disease. Studies have also demonstrated the benefit of particular classes of antihypertensive agents in certain patient groups. Research is beginning to elucidate the problems of hypertension in the acute phase of ischaemic stroke and the therapeutic strategies that may be helpful. Given the significant impact of stroke disease on all health services, it remains an important priority to determine the best management of hypertension in stroke.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062601     DOI: 10.1007/s11906-996-0040-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  51 in total

1.  Controlling hypertension in the elderly.

Authors:  C J Bulpitt
Journal:  QJM       Date:  2000-04

2.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

3.  Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

Authors:  L Liu; J G Wang; L Gong; G Liu; J A Staessen
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

4.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

Review 5.  Circadian variation in blood pressure: implications for the elderly patient.

Authors:  W J Elliott
Journal:  Am J Hypertens       Date:  1999-02       Impact factor: 2.689

6.  Endothelin-1-induced interleukin-8 production in human brain-derived endothelial cells is mediated by the protein kinase C and protein tyrosine kinase pathways.

Authors:  R Zidovetzki; P Chen; M Chen; F M Hofman
Journal:  Blood       Date:  1999-08-15       Impact factor: 22.113

7.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

8.  Hypertension and its treatment in the NINDS rt-PA Stroke Trial.

Authors:  T Brott; M Lu; R Kothari; S C Fagan; M Frankel; J C Grotta; J Broderick; T Kwiatkowski; C Lewandowski; E C Haley; J R Marler; B C Tilley
Journal:  Stroke       Date:  1998-08       Impact factor: 7.914

9.  Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association.

Authors:  H P Adams; T G Brott; A J Furlan; C R Gomez; J Grotta; C M Helgason; T Kwiatkowski; P D Lyden; J R Marler; J Torner; W Feinberg; M Mayberg; W Thies
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

Review 10.  [Apoplexy with rapidly deteriorating symptoms--"stroke in progression". Hemodynamic and clinical aspects].

Authors:  E Garde; N A Lassen
Journal:  Ugeskr Laeger       Date:  1995-07-24
View more
  1 in total

1.  Factors of non-compliance with the therapeutic regimen among hypertensive men and women: a case-control study to investigate risk factors of stroke.

Authors:  B Th Baune; Y Aljeesh; R Bender
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.